Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Marina ParryJ C Strefford

Abstract

Mounting evidence supports the clinical significance of gene mutations and immunogenetic features in common mature B-cell malignancies. We undertook a detailed characterization of the genetic background of splenic marginal zone lymphoma (SMZL), using targeted resequencing and explored potential clinical implications in a multinational cohort of 175 patients with SMZL. We identified recurrent mutations in TP53 (16%), KLF2 (12%), NOTCH2 (10%), TNFAIP3 (7%), MLL2 (11%), MYD88 (7%), and ARID1A (6%), all genes known to be targeted by somatic mutation in SMZL. KLF2 mutations were early, clonal events, enriched in patients with del(7q) and IGHV1-2*04 B-cell receptor immunoglobulins, and were associated with a short median time to first treatment (0.12 vs. 1.11 years; P = 0.01). In multivariate analysis, mutations in NOTCH2 [HR, 2.12; 95% confidence interval (CI), 1.02-4.4; P = 0.044] and 100% germline IGHV gene identity (HR, 2.19; 95% CI, 1.05-4.55; P = 0.036) were independent markers of short time to first treatment, whereas TP53 mutations were an independent marker of short overall survival (HR, 2.36; 95 % CI, 1.08-5.2; P = 0.03). We identify key associations between gene mutations and clinical outcome, demonstrating for the first t...Continue Reading

References

May 23, 2001·Blood·A M Gruszka-WestwoodD Catovsky
Mar 5, 2003·British Journal of Haematology·Nilima Parry-JonesDaniel Catovsky
Feb 24, 2006·Blood·Luca ArcainiUNKNOWN Integruppo Italiano Linfomi
Oct 2, 2007·The International Journal of Biochemistry & Cell Biology·Richard PearsonShisan Bao
Dec 24, 2010·Nature·Vu N NgoLouis M Staudt
Dec 29, 2010·Proceedings of the National Academy of Sciences of the United States of America·Geoffrey T HartStephen C Jameson
Mar 11, 2011·Nature·Laura PasqualucciRiccardo Dalla-Favera
May 1, 2012·Nature Biotechnology·Scott L CarterGad Getz
Jul 5, 2012·Genome Research·Nathan D DeesLi Ding
Aug 15, 2012·The Journal of Experimental Medicine·Mark J KielKojo S J Elenitoba-Johnson
Sep 4, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Geoffrey T HartStephen C Jameson
Jun 27, 2013·Leukemia & Lymphoma·Carlos MontalbanUNKNOWN Splenic Marginal Zone Lymphoma Study Group (SMZLSG)
Oct 16, 2013·The Journal of Experimental Medicine·Giulia FabbriRiccardo Dalla-Favera

❮ Previous
Next ❯

Citations

Mar 19, 2016·Blood·Luca ArcainiMarco Paulli
Jun 24, 2016·Blood·Valeria SpinaDavide Rossi
Apr 11, 2017·Journal of Internal Medicine·P GhiaF K Stevenson
Jun 1, 2017·Biomedicines·Véronique Imbert, Jean-François Peyron
Jul 1, 2017·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Arantza OnaindiaKeyur P Patel
Feb 27, 2019·Current Oncology Reports·Marine BaronVéronique Leblond
Oct 18, 2019·Expert Review of Hematology·Lori A LeslieAndre H Goy
Jul 26, 2018·Oncotarget·Jacob E Robinson, Christine E Cutucache
Sep 17, 2018·Diagnostic Pathology·Katherine WickendenMatthew J Ahearne
Mar 8, 2020·Histopathology·Francisca Inmaculada Camacho CastañedaSocorro María Rodríguez Pinilla
May 17, 2018·American Journal of Clinical Pathology·Matthew M KlairmontJoel F Gradowski
Sep 6, 2018·Journal of Community Hospital Internal Medicine Perspectives·Oreoluwa OladiranAnthony Donato
Aug 1, 2020·The Cancer Journal·Francesco BertoniEmanuele Zucca
Jul 28, 2016·Cold Spring Harbor Perspectives in Medicine·Ana I RoblesCurtis C Harris
Feb 12, 2017·Clinical Science·Christina A EichstaedtEkkehard Grünig
Jun 21, 2017·Journal of Internal Medicine·R RosenquistQ Pan-Hammarström
Dec 12, 2018·Frontiers in Oncology·Francesca ArrugaSilvia Deaglio
Nov 5, 2019·Frontiers in Genetics·Marcelo L RibeiroGaël Roué
Dec 27, 2016·Frontiers in Oncology·Chelsey L Patten, Christine E Cutucache
Mar 25, 2018·Current Oncology Reports·Sabarish Ayyappan, Basem M William
Apr 17, 2018·F1000Research·Francesco BertoniEmanuele Zucca
Jul 20, 2019·Scientific Reports·Carolina Jaramillo OquendoJonathan C Strefford
Jan 15, 2020·Cold Spring Harbor Perspectives in Medicine·Nathanael G Bailey, Kojo S J Elenitoba-Johnson
Jun 11, 2020·The American Journal of Surgical Pathology·Stephanie N HurwitzAdam Bagg
Mar 10, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tatjana PandzicMats Hellström
Jul 30, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stéphanie PoulainXavier Leleu
Aug 26, 2020·Seminars in Diagnostic Pathology·Julia T GeyerAttilio Orazi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.